Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 7 Apr 20 SC TO-T/A Third party tender offer statement (amended)
- 30 Mar 20 SC TO-T/A Third party tender offer statement (amended)
- 23 Mar 20 SC TO-T/A Third party tender offer statement (amended)
- 17 Mar 20 SC TO-T/A Third party tender offer statement (amended)
- 12 Mar 20 SC TO-T/A Third party tender offer statement (amended)
- 10 Mar 20 SC TO-T Third party tender offer statement
- 3 Mar 20 SC TO-C Information about tender offer
-
2 Mar 20 SC TO-C Information about tender offer
- 2 Mar 20 SC TO-C Information about tender offer
GILD similar filings
Related company
Filing view
External links
Gilead Tweet (@GileadSciences), March 2, 2020
Today we announced that we will acquire @FortySevenInc, a clinical-stage immuno-oncology company. This transaction supports our strategic focus in oncology and gives access to a potential new first-in-class program.
Read more: http://bit.ly/2wl2Jhk.